Major shareholder announcement

Udgivet den 14-06-2015  |  kl. 09:20  |  

Valby, Denmark, 14 June 2015 - H. Lundbeck A/S (Lundbeck) today announced that pursuant to Section 29 of the Danish Securities Trading Act it is hereby announced that Wellington Management Group LLP has reduced its indirect ownership share in Lundbeck to below 5% of the share capital and voting rights in the company.

Lundbeck contacts

 

Investors: Media:
   
Palle Holm Olesen Mads Kronborg
Vice President,  Investor Relations Director, Media Relations
PALO@lundbeck.com MAVK@lundbeck.com
+45 36 43 24 26 +45 36 43 30 00

About Lundbeck

H. Lundbeck A/S (LUN.CO, LUN DC, HLUYY) is a global pharmaceutical company specialized in brain diseases. For more than 50 years, we have been at the forefront of research within neuroscience. Our key areas of focus are alcohol dependence, Alzheimer’s disease, bipolar disorder, depression/anxiety, epilepsy, Huntington’s disease, Parkinson’s disease, schizophrenia and symptomatic neurogenic orthostatic hypotension (NOH).

An estimated 700 million people worldwide are living with brain disease and far too many suffer due to inadequate treatment, discrimination, a reduced number of working days, early retirement and other unnecessary consequences. Every day, we strive for improved treatment and a better life for people living with brain disease – we call this Progress in Mind.

Read more at www.lundbeck.com/global/about-us/progress-in-mind.

Our approximately 6,000 employees in 57 countries are engaged in the entire value chain throughout research, development, production, marketing and sales. Our pipeline consists of several late-stage development programs and our products are available in more 100 countries. We have research centers in China, Denmark and the United States and production facilities in China, Denmark, France and Italy. Lundbeck generated revenue of approximately DKK 13.5 billion in 2014 (EUR 1.8 billion; USD 2.4 billion).

Lundbeck’s shares are listed on the stock exchange in Copenhagen under the symbol ”LUN”. Lundbeck has a sponsored Level 1 ADR program listed in the US (OTC) under the symbol ”HLUYY”.

For additional information, we encourage you to visit our corporate site www.lundbeck.com.

 

Vedhæftede filer:

Major Shareholder_UK.pdf

Udgivet af: NPinvestordk

Seneste nyheder

17:48 Europa/aktier: AI-bekymringer blev opvejet af kemikalieoptimisme i fladt marked
17:21 Novo sagsøgt af investor efter data fra fedmeforsøg med Cagrisema
17:06 Mandagens aktier: Novonesis og Pandora sørgede for grønt C25 trods AI-tumult - KORR
17:03 Mandagens aktier: Novonesis og Pandora sørgede for grønt C25 trods AI-tumult
17:01 Mandagens obligationer: Lille rentefald efter falmet AI-hype og bedre tysk erhvervstillid
16:52 Kemivirksomheder i fremgang på dobbelt løft af anbefaling fra JPMorgan
15:45 Nvidia saves over fra start: Aktie trykkes ned med tæt på 12 pct. af kinesisk AI-robot
15:37 Visma har fået tilsagn nok til at tage dansk signeringtjeneste af børsen
15:37 USA/åbning: Nvidia og GE Vernova får mavepuster af kinesisk AI-robot
15:09 Schweizisk investeringsbank sætter gang i hundredvis af fyringer i spareplan
14:54 USA/tendens: Kinesisk AI-robot sender Nvidia og teknologi i dybet
14:22 Amerikansk techaktier sendes i hullet af kinesisk AI-konkurrence
13:47 Europa/aktier: Deepseeks AI-robot ødelægger humøret for teknologi- og energiinvestorerne
13:39 Hamas: Liste viser at 25 af 33 gidsler til frigivelse er i live
13:36 Valutahandlerne sejler i sikker havn i Japan og Schweiz
13:25 Mineselskab udnævnt som muligt opkøbsmål i 2025
13:11 Grønlandsbanken: Bestyrelsesmedlem er afgået ved døden
12:36 Telegiganten AT&T slår forventningerne i fjerde kvartal efter stor kundetilvækst
12:22 EU forlænger sanktioner mod Rusland i yderligere seks måneder
12:03 Danske Bank efter technedtur: Regnskaber fra giganter kan vende stemningen